0      0


Car-T Therapy's impact on the Patient Pathway


Mar 23, 2020 1:45pm ‐ Mar 23, 2020 2:45pm


Credits: None available.

Description

While we are all aware of the potential that precision medicine promises, can we effectively design facilities to accommodate these novel therapies? This session will present HDR's research on this topic. We will review how the question our City of Hope client asked about Car-T cell therapy impact on inpatient volume turned into a six-month-long research study. During this session you will be provided with case studies from prominent cancer institutions on their facility responses. Also, HDR will demonstrate our analytical tools that quantify the impact that Cytokine Release Syndrome has on immunotherapy readmission and how this impacts the metrics for inpatient bed need.

Learning Objectives:
  • Produce an informed response to a difficult programming question
  • Evaluate built facilities’ responses to novel therapies
  • Assess how parametric modeling can assist in analyzing inpatient metrics
  • View how future patient pathways impact facility design

Speaker(s):

Credits

Credits: None available.

You must be logged in and own this session in order to post comments.

Print Certificate
Completed on: token-completed_on
Print Transcript
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content